Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.

Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Abstract Text:

    obdulio pilotoObdulio Piloto,melissa wrightMelissa Wright,patrick brownPatrick Brown,kyu-tae kimKyu-Tae Kim,mark levisMark Levis,donald smallDonald Small,

    Continuous treatment of malignancies with tyrosine kinase inhibitors (TKIs) may select for resistant clones (ie, imatinib mesylate). To study resistance to TKIs targeting FLT3, a receptor tyrosine kinase that is frequently mutated in acute myelogenous leukemia (AML), we developed resistant human cell lines through prolonged coculture with FLT3 TKIs. FLT3 TKI-resistant cell lines and primary samples still exhibit inhibition of FLT3 phosphorylation on FLT3 TKI treatment. However, FLT3 TKI-resistant cell lines and primary samples often show continued activation of downstream PI3K/Akt and/or Ras/MEK/MAPK signaling pathways as well as continued expression of genes involved in FLT3-mediated cellular transformation. Inhibition of these signaling pathways restores partial sensitivity to FLT3 TKIs. Mutational screening of FLT3 TKI-resistant cell lines revealed activating N-Ras mutations in 2 cell lines that were not present in the parental FLT3 TKI-sensitive cell line. Taken together, these data indicate that FLT3 TKI-resistant cells most frequently become FLT3 independent because of activation of parallel signaling pathways that provide compensatory survival/proliferation signals when FLT3 is inhibited. Anti-FLT3 mAb treatment was still cytotoxic to FLT3 TKI-resistant clones. An approach combining FLT3 TKIs with anti-FLT3 antibodies and/or inhibitors of important pathways downstream of FLT3 may reduce the chances of developing resistance.

    Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Publishing Authors By Initials

    o pilotoO Piloto,m wrightM Wright,p brownP Brown,kt kimKT Kim,m levisM Levis,d smallD Small,

    For similar enzymes and coenzymes: enzymes: hydrolases: acid anhydride hydrolases: gtp phosphohydrolases: gtp-binding proteins: monomeric gtp-binding proteins: ras proteins research abstracts see: enzymes and coenzymes: enzymes: hydrolases: acid anhydride hydrolases: gtp phosphohydrolases: gtp-binding proteins: monomeric gtp-binding proteins: ras proteins research

    PUBMED ID PMID:

    MEDLINE DATE:

    Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Blood

    VOLUME: 109

    Page Numbers: 1643-52

    Journal Abbreviation: Blood

    ISSN: 0006-4971

    DAY: 17

    MONTH: 10

    YEAR: 2006

    Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7603509

    Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Keywords Mesh Terms:

    KEYWORDS: ras Proteins

    MESH TERMS: genetics

    Chemical & Substance for Abstract: Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways. Information

    Substance Name: ras Proteins

    Registry Number: EC 3.6.5.2

    Grant and Affiliation Information for Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways.

    AFFILIATION: Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21202, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NCI

    GRANT: CA95600-03

    ACRONYM: CA

    MEDLINETA: Blood

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News